Managing IP hosted the successful forum, MIP European Life Sciences Forum on June 29 in London.The Forum tracked legislative developments within the life sciences sector, identifying key cases in the complex fast-moving world of supplementary protection certificates, future of IP regulatory approvals in the UK and identifying procedural tactics to make companies IPR ready.Attendees were able to:
REGISTRATION & MARKETING QUERIESIris Tangregistrations@managingip.com+44 (0) 207 779 8564SPEAKING ENQUIRIESNatalie Canternatalie.firstname.lastname@example.org+44 (0) 207 779 8730SPONSORSHIP ENQUIRIESMelanie Petchmpetch@euromoneyplc.com+44 (0) 207 779 8836
European Commission approves Qualcomm's acquisition of NXP, subject to conditions https://t.co/0LQaJUbYmm Qualcomm… https://t.co/sk8YHNFZny
easyGroup loses trade mark fight against EasyRoommate https://t.co/RbXV5TJ8Cn Property letting business doesn't inf… https://t.co/gPvR1fnvdP
RT @business: Google and Tencent have agreed to share patents https://t.co/QmS9nhkf3Y https://t.co/lc3lFOo9EF
End of Year 2017
Tribal sovereign immunity: Taking a wrecking ball to the IPR system
The lawyer behind Allergan’s controversial transfer of patents to a Native American tribe says others are “lining up to do deals”. But, Michael Loney asks, will the PTAB rule that sovereign immunity applies in these types of deals?
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2018 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International